Klugman KP - Search Results

1

Fluoroquinolone-resistant Streptococcus pneumoniae, an emerging but unrecognized public health concern: is it time to resight the goalposts?

Ambrose PG, Bast D, Doern GV, Iannini PB, Jones RN, Klugman KP, Low DE. Ambrose PG, et al. Among authors: klugman kp. Clin Infect Dis. 2004 Nov 15;39(10):1554-6; author reply 1556-7. doi: 10.1086/425508. Clin Infect Dis. 2004. PMID: 15546106 No abstract available.

2

Rationale for revised penicillin susceptibility breakpoints versus Streptococcus pneumoniae: coping with antimicrobial susceptibility in an era of resistance.

Weinstein MP, Klugman KP, Jones RN. Weinstein MP, et al. Among authors: klugman kp. Clin Infect Dis. 2009 Jun 1;48(11):1596-600. doi: 10.1086/598975. Clin Infect Dis. 2009. PMID: 19400744 Review.

3

The battle against emerging antibiotic resistance: should fluoroquinolones be used to treat children?

Mandell LA, Peterson LR, Wise R, Hooper D, Low DE, Schaad UB, Klugman KP, Courvalin P. Mandell LA, et al. Among authors: klugman kp. Clin Infect Dis. 2002 Sep 15;35(6):721-7. doi: 10.1086/341900. Epub 2002 Aug 20. Clin Infect Dis. 2002. PMID: 12203170

4

Surveillance of resistance in bacteria causing community-acquired respiratory tract infections.

Felmingham D, Feldman C, Hryniewicz W, Klugman K, Kohno S, Low DE, Mendes C, Rodloff AC. Felmingham D, et al. Clin Microbiol Infect. 2002;8 Suppl 2:12-42. doi: 10.1046/j.1469-0691.8.s.2.5.x. Clin Microbiol Infect. 2002. PMID: 12427206 Free article. Review.

5

High-level telithromycin resistance in a clinical isolate of Streptococcus pneumoniae.

Wolter N, Smith AM, Low DE, Klugman KP. Wolter N, et al. Among authors: klugman kp. Antimicrob Agents Chemother. 2007 Mar;51(3):1092-5. doi: 10.1128/AAC.01153-06. Epub 2007 Jan 8. Antimicrob Agents Chemother. 2007. PMID: 17210764 Free PMC article.

6

Community-acquired pneumonia: new management strategies for evolving pathogens and antimicrobial susceptibilities.

Klugman KP, Low DE, Metlay J, Pechere JC, Weiss K. Klugman KP, et al. Int J Antimicrob Agents. 2004 Nov;24(5):411-22. doi: 10.1016/j.ijantimicag.2004.08.006. Int J Antimicrob Agents. 2004. PMID: 15519470 Review.

7

Future trends in antimicrobial chemotherapy: expert opinion on the 43rd ICAAC.

Ball AP, Bartlett JG, Craig WA, Drusano GL, Felmingham D, Garau JA, Klugman KP, Low DE, Mandell LA, Rubinstein E, Tillotson GS. Ball AP, et al. Among authors: klugman kp. J Chemother. 2004 Oct;16(5):419-36. doi: 10.1179/joc.2004.16.5.419. J Chemother. 2004. PMID: 15565907 Review.

8

Antibiotic therapy of community respiratory tract infections: strategies for optimal outcomes and minimized resistance emergence.

Ball P, Baquero F, Cars O, File T, Garau J, Klugman K, Low DE, Rubinstein E, Wise R; Consensus Group on Resistance and Prescribing in Respiratory Tract Infection. Ball P, et al. J Antimicrob Chemother. 2002 Jan;49(1):31-40. doi: 10.1093/jac/49.1.31. J Antimicrob Chemother. 2002. PMID: 11751764 Review.

9

Fluoroquinolone-resistant Streptococcus pneumoniae.

Pletz MW, Fugit RV, McGee L, Glasheen JJ, Keller DL, Welte T, Klugman KP. Pletz MW, et al. Among authors: klugman kp. Emerg Infect Dis. 2006 Sep;12(9):1462-3. doi: 10.3201/eid1209.051400. Emerg Infect Dis. 2006. PMID: 17073107 Free PMC article. No abstract available.

10

The role of clonality in the global spread of fluoroquinolone-resistant bacteria.

Klugman KP. Klugman KP. Clin Infect Dis. 2003 Mar 15;36(6):783-5. doi: 10.1086/367935. Epub 2003 Mar 4. Clin Infect Dis. 2003. PMID: 12627363 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

516 results

Search Page

Filters